<DOC>
	<DOCNO>NCT00604331</DOCNO>
	<brief_summary>Pyruvate intermediate energy metabolism show posse pronounce positive inotropic effect vitro vivo without alter myocardial oxygen consumption . Moreover , show effect beta-adrenergic stimulation potentiate . Thus , might possible save catecholamine patient severe heart failure cardiogenic shock . This study design test hemodynamic effect pyruvate administer coronary artery addition intra-aortic balloon pump counterpulsation patient severe heart failure patient acute myocardial infarction cardiogenic shock perform percutaneous coronary intervention . A pronounced improvement hemodynamics expect occur .</brief_summary>
	<brief_title>Effects Pyruvate Patients With Cardiogenic Shock Intra-aortic Balloon Counterpulsation</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Cardiogenic</mesh_term>
	<criteria>Hospitalized patient male/female Age : 18 85 year Weight : 45 110 kg Height 150 195 cm Clinically sign heart failure ( NYHA IIIIV ) refractary therapy cardiogenic shock acute myocardial infarction write informed consent witness verbal consent presume ( compassionate use ) Malignoma Clinically significant cardiac valve stenosis Participation another clinical trial relevant probable druginteractions Pregnancy lactation Addiction Poor compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Pyruvic Acid</keyword>
	<keyword>Shock , Cardiogenic</keyword>
	<keyword>Catecholamines</keyword>
	<keyword>Intra-Aortic Balloon Pumping</keyword>
	<keyword>Cardiac Output</keyword>
	<keyword>Cardiac Index</keyword>
	<keyword>Cardiac Function</keyword>
</DOC>